Rhabdomyosarcomas are oncogene addicted to the activation of AVIL
Open Access
- 6 June 2022
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (24)
Abstract
Significance: Rhabdomyosarcoma (RMS) is a common pediatric soft-tissue cancer. There are two main subtypes driven by distinct mechanisms. Currently, there is no targeted therapy for the disease. We found an oncogene AVIL, whose activity is often abnormally up-regulated in RMS. Silencing the gene kills RMS cells and prevents tumor formation in animals; yet, normal control cells are indifferent to the interference. Mechanistically, AVIL activation turns on both oncogene pathways in RMS. These findings support that AVIL may be a good therapeutic target and that targeting AVIL may be a viable approach for both types of RMS.Keywords
Funding Information
- HHS | NIH | National Cancer Institute (R01CA240601)
This publication has 28 references indexed in Scilit:
- Human Rhabdomyosarcoma Cell Lines for Rhabdomyosarcoma Research: Utility and PitfallsFrontiers in Oncology, 2013
- Genome-Wide Identification of PAX3-FKHR Binding Sites in Rhabdomyosarcoma Reveals Candidate Target Genes Important for Development and CancerCancer Research, 2010
- Fusion Gene-Negative Alveolar Rhabdomyosarcoma is Clinically and Molecularly Indistinguishable from Embryonal RhabdomyosarcomaJournal of Clinical Oncology, 2010
- Molecular Classification of Rhabdomyosarcoma—Genotypic and Phenotypic Determinants of DiagnosisThe American Journal of Pathology, 2009
- Mouse Mesenchymal Stem Cells Expressing PAX-FKHR Form Alveolar Rhabdomyosarcomas by Cooperating with Secondary MutationsCancer Research, 2008
- EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem CellsCancer Research, 2008
- Global gene expression profiling of PAX‐FKHR fusion‐positive alveolar and PAX‐FKHR fusion‐negative embryonal rhabdomyosarcomasThe Journal of Pathology, 2007
- Identification of a PAX-FKHR Gene Expression Signature that Defines Molecular Classes and Determines the Prognosis of Alveolar RhabdomyosarcomasCancer Research, 2006
- DNA Microarrays Reveal Relationship of Ewing Family Tumors to Both Endothelial and Fetal Neural Crest-Derived Cells and Define Novel TargetsCancer Research, 2004
- Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequencesProceedings of the National Academy of Sciences, 2002